Harm Reduction Therapeutics

Harm Reduction Therapeutics is a nonprofit pharmaceutical company based in the United States. Small in size with a team of four employees, the company focuses on developing and distributing harm reduction therapies. Their primary product is naloxone, a medication that reverses opioid overdoses. Harm Reduction Therapeutics aims to make naloxone accessible to the public at an affordable price to combat the opioid crisis and reduce overdose deaths. They target individuals at risk of opioid overdose, including those struggling with addiction and their families, as well as first responders and community members. The company distinguishes itself through its commitment to public health and its mission-driven approach. By prioritizing affordability and accessibility, Harm Reduction Therapeutics seeks to make naloxone a readily available resource for everyone who needs it. To learn more about Harm Reduction Therapeutics and their work, visit their website at harmreductiontherapeutics.org.